AbCellera Biologics Inc.
2.78
-0.22 (-7.33%)
At close: Jan 14, 2025, 3:59 PM
2.85
2.52%
Pre-market Jan 15, 2025, 09:03 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 38.02M 485.42M 375.20M 233.16M 11.61M 8.83M
Cost of Revenue n/a 66.44M 45.52M 27.14M 10.11M 5.80M
Gross Profit 38.02M 418.99M 329.69M 206.01M 1.50M 3.03M
Operating Income -237.21M 216.51M 204.41M 156.03M -4.12M -753.00K
Interest Income 42.25M 16.08M 3.33M 293.00K 154.96K 42.00K
Pretax Income -174.03M 239.10M 219.15M 157.83M -2.21M 309.00K
Net Income -146.40M 158.52M 153.46M 118.92M -2.42M 309.00K
Selling & General & Admin 75.18M 66.75M 48.76M 15.75M 4.01M 2.86M
Research & Development 175.66M 107.88M 62.06M 29.39M 10.11M 5.80M
Other Expenses 24.39M 17.29M -3.04M -3.48M -170.41K -675.51K
Operating Expenses 275.23M 191.92M 107.79M 41.66M 13.95M 7.99M
Interest Expense n/a 4.04M 5.22M 6.51M 209.20K 212.00K
Selling & Marketing Expenses 14.18M 11.27M 6.91M 3.84M 1.26M 712.00K
Cost & Expenses 275.23M 258.36M 153.30M 68.80M 13.95M 7.99M
Income Tax -27.63M 80.58M 65.69M 38.91M 209.20K 1.27M
Shares Outstanding (Basic) 289.17M 285.06M 275.76M 269.50M 154.09M 237.72M
Shares Outstanding (Diluted) 289.17M 314.83M 318.29M 269.50M 154.09M 237.72M
EPS (Basic) -0.51 0.56 0.56 0.44 -0.02 0.00
EPS (Diluted) -0.51 0.50 0.48 0.44 -0.02 0.00
EBITDA -192.16M 272.20M 241.62M 169.62M -397.42K 165.00K
Depreciation & Amortization 30.89M 33.10M 17.25M 5.27M 1.60M 918.46K

Create Price Alert on ABCL

Your price alert will notify you when the stock price is above 2.78.

Add to Watchlist